B7-H3 is eligible for predicting clinical outcomes in lung adenocarcinoma patients treated with EGFR tyrosine kinase inhibitors

بواسطة Ying Yang, Jun-feng Huang, Bing-qi Hu, Jing Zhou, Xian Wang, Zhen-zhong Feng, Yu-ting Chen, Fa-ming Pan, Huai-dong Cheng, Li-wen Chen
منشور في 2022-05-01